Trimethoprim-sulfamethoxazole Induced Pancytopenia: A Common Occurrence but A Rare Diagnosis
- PMID: 31516782
- PMCID: PMC6721910
- DOI: 10.7759/cureus.5071
Trimethoprim-sulfamethoxazole Induced Pancytopenia: A Common Occurrence but A Rare Diagnosis
Abstract
Trimethoprim-sulfamethoxazole (TMP-SMX) is a bacteriostatic antimicrobial medication used for the treatment of a variety of infections and has many reported skin and hematologic side effects. Due to the easy availability and cost effectiveness, TMP-SMX is one of the medications commonly used for treatment of skin and soft tissue in patients with methicillin-resistant Staphylococcus aureus (MRSA) infection. One of the rare hematologic manifestations of TMP-SMX is pancytopenia, which is a reduction in all cell lines. In this case report, we are documenting a case of pancytopenia due to severe drug reaction to TMP-SMX in a 70-year-old female after two weeks of medication use. Upon initial stabilization she underwent a thorough workup and was subsequently diagnosed with severe drug-induced pancytopenia. Detailed history, early diagnosis, prompt discontinuation of the offending medication along with supportive care remain the mainstay of treatment in the management of TMP-SMX induced pancytopenia.
Keywords: bactrim; mrsa; pancytopenia; tmp-smx; trimethoprim sulfamethoxazole.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


References
-
- Acute-onset pancytopenia in a previously healthy teenager. Crews J, Dawkins R. J Paediatr Neonatal Dis. 2016;1:105.
-
- Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Liu C, Bayer A, Cosgrove SE, et al. Infect Dis. 2011;52:0. - PubMed
-
- Sulfonamides and trimethoprim . Kalkut G. Cancer Invest. 2009;16:612–615. - PubMed
Publication types
LinkOut - more resources
Full Text Sources